Robotic gastrectomy for gastric cancer

Son, Taeil; Hyung, Woo Jin

doi:10.1002/jso.23926

Cited by 31 publications

(16 citation statements)

References 85 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Over the last 20 years, the safety and oncologic efficacy of laparoscopic gastrectomy has been studied, perhaps most notably by the Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group and the Japanese Laparoscopic Surgery Study Group (JLSSG) [3][4][5][6]. The recent implementation of robotic technology has further added to the armamentarium of surgical oncologists, providing a corresponding ease with which surgical dissections are performed [7][8][9].…”

Section: Introductionmentioning

confidence: 99%

Minimally invasive surgery for gastric cancer: the American experience

et al. 2016

View full text Add to dashboard Cite

Background Minimally invasive surgical techniques are increasingly being implemented in oncologic care. This study assesses the impact of minimally invasive surgery on oncologic and perioperative outcomes in the management of gastric cancer in the USA. Methods From the American College of Surgeons and American Cancer Society National Cancer Data Base, we identified 6427 patients who underwent gastrectomy for cancer from 2010 to 2012. Treatment groups were categorized with an intention-to-treat paradigm as robotic, laparoscopic, and open surgery. Univariate and multivariate analyses were performed to estimate the impact of the surgical approach on oncologic and perioperative outcomes. Results Of patients undergoing definitive surgical intervention, 3.5 % (n = 223) underwent robotic gastrectomy, 23.1 % (n = 1487) underwent laparoscopic gastrectomy, and 73.4 % (n = 4717) underwent open surgery. Minimally invasive gastrectomy was more frequently performed on white (P = 0.018), privately insured patients (P = 0.049) treated at academic centers (P \ 0.0001) in the eastern USA (P \ 0.0001). After demographics, comorbidities, and tumor-related factors had been controlled for, patients who underwent laparoscopic gastrectomy had the postoperative length of stay decreased by 1.08 days (P \ 0.0001) and greater odds of having at least 15 lymph nodes resected (odds ratio 1.16, P = 0.023). Use of robotic surgery did not have a statistically significant effect on the postoperative length of stay relative to open surgery (P = 0.222) but the patients so treated had greater odds of having at least 15 lymph nodes resected (odds ratio 1.51, P = 0.005). There were no differences in R0 resection rates or perioperative mortality on the basis of the surgical approach alone. Conclusions These findings suggest that use of minimally invasive surgery for gastric cancer in the USA is impacting the adequacy of oncologic resection but is not yet having a clinically significant impact on perioperative outcomes relative to a conventional open approach.

show abstract

Section: Introductionmentioning

confidence: 99%

Minimally invasive surgery for gastric cancer: the American experience

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Image‐guided navigation helps to properly identify stomach vasculature and eliminate the possibility of vascular injuries 4, 52. These techniques are more advanced in other fields such as neurosurgery and orthopedic surgery.…”

Section: New Technologies In Robotic Surgery Systemmentioning

confidence: 99%

“…Since robotic surgery was first introduced in the late 1990s, wide application and accumulation of experience have continued 2, 3. Moreover, it has overcome some of the limitations of conventional laparoscopy by providing increased accuracy of tremor filtered and wristed instrumental movements, along with seven degrees of freedom and the ability to scale motions 4, 5…”

Section: Introductionmentioning

confidence: 99%

Robotic gastrectomy for gastric cancer: Current evidence

Alhossaini

Altamran

Seo

et al. 2017

Annals of Gastroent Surgery

Self Cite

View full text Add to dashboard Cite

The robotic system has gained wide acceptance in specialties such as urological and gynecological surgery. It has also been applied in the field of upper gastrointestinal surgery. Since the first implementation of the robotic system for the treatment of gastric adenocarcinoma, the procedure has been found to be safe and feasible. Although robotic gastrectomy does not meet our expectations and yield better results than laparoscopic gastrectomy, this procedure seems to provide several advantages over laparoscopy such as reduced blood loss, shorter learning curves and increased number of retrieved lymph nodes. However, as many case series, including a recent multicenter study, have revealed, higher cost and longer operation time are the major limitations of robotic gastrectomy. Furthermore, there are no results from well‐designed randomized clinical trials comparing the two procedures. New procedures in much more technically demanding cases will test the genuine benefits of robotic gastrectomy.

show abstract

“…To date, several review articles[10,19,51-55] have been published which provide a critical appraisal of the effectiveness of RAG for gastric cancer, but they are not systematic research and do not actually supply any statistical comparative analysis. Thus, the usefulness of these articles is essentially of scientific expounding and debating, they do not add any new knowledge to that so far evidenced by clinical studies.…”

Section: Literature Evidencementioning

confidence: 99%

Robot-assisted laparoscopic gastrectomy for gastric cancer

Caruso¹,

Franceschini²,

Patriti³

et al. 2017

WJGE

View full text Add to dashboard Cite

Phase III evidence in the shape of a series of randomized controlled trials and meta-analyses has shown that laparoscopic gastrectomy is safe and gives better short-term results with respect to the traditional open technique for early-stage gastric cancer. In fact, in the East laparoscopic gastrectomy has become routine for early-stage gastric cancer. In contrast, the treatment of advanced gastric cancer through a minimally invasive way is still a debated issue, mostly due to worries about its oncological efficacy and the difficulty of carrying out an extended lymphadenectomy and intestinal reconstruction after total gastrectomy laparoscopically. Over the last ten years the introduction of robotic surgery has implied overcoming some intrinsic drawbacks found to be present in the conventional laparoscopic procedure. Robot-assisted gastrectomy with D2 lymphadenectomy has been shown to be safe and feasible for the treatment of gastric cancer patients. But unfortunately, most available studies investigating the robotic gastrectomy for gastric cancer compared to laparoscopic and open technique are so far retrospective and there have not been phase III trials. In the present review we looked at scientific evidence available today regarding the new high-tech surgical robotic approach, and we attempted to bring to light the real advantages of robot-assisted gastrectomy compared to the traditional laparoscopic and open technique for the treatment of gastric cancer.

show abstract

Robotic gastrectomy for gastric cancer

Cited by 31 publications

References 85 publications

Minimally invasive surgery for gastric cancer: the American experience

Minimally invasive surgery for gastric cancer: the American experience

Robotic gastrectomy for gastric cancer: Current evidence

Robot-assisted laparoscopic gastrectomy for gastric cancer

Contact Info

Product

Resources

About